The most advanced treatment for stroke prevention in atrial Fibrillation
WATCHMAN is an implantable device that can help patients with severe bleeding risk on blood thinners such as Coumadin.
WATCHMAN offers an alternative to the lifelong use of warfarin for people with atrial fibrillation not caused by a heart valve problem (also known as non-valvular AFib).
This permanent heart implant effectively reduces the risk of stroke—without the risk of bleeding that can come with the long-term use of warfarin (the most common blood thinner). What’s more, WATCHMAN can eliminate the regular blood tests and food-and-drink restrictions that come with warfarin. (Warfarin is also known as Coumadin®.)
WATCHMAN is the only device of its kind approved by the U.S. Food and Drug Administration (FDA) for reducing the risk of stroke in people with atrial fibrillation not caused by a heart valve problem. More than 100,000 WATCHMAN procedures have been performed worldwide. And with over 10 years of U.S. clinical studies behind it, WATCHMAN has a proven safety record.
Atrial fibrillation, or AFib, affects your heart’s ability to pump blood normally. This can cause blood to pool in an area of the heart called the left atrial appendage, or LAA. There, blood cells can stick together and form a clot. When a blood clot escapes from the LAA and travels to another part of the body, it can cut off the blood supply to the brain, causing a stroke.
In people with AFib not caused by a heart valve problem, more than 90% of stroke-causing clots that come from the heart are formed in the LAA. That’s why closing off this part of the heart is an effective way to reduce stroke risk.
The WATCHMAN Implant fits right into your LAA. It’s designed to permanently close it off and keep those blood clots from escaping. WATCHMAN is about the size of a quarter and made from very light and compact materials commonly used in many other medical implants.
Dr. Sirulnick is an expert on this procedure and was the first in Nevada to offer this type of therapy.